期刊文献+

SphK1在胃癌中的表达及其临床意义 被引量:4

Expression of SphK1 in gastric cancer and its clinical significance
下载PDF
导出
摘要 目的探讨鞘氨醇激酶1(SphK1)在胃癌发生、发展中的作用及其与血管内皮生长因子(VEGF)的相关性。方法收集2011年5月至2011年8月经手术切除的31例胃癌及其癌旁组织标本,用实时荧光定量PCR法检测组织标本中SphK1 mRNA的表达量;免疫组化法检测SphK1和VEGF的蛋白表达水平。结果 SphK1 mRNA在胃癌织中的表达量为2.77±0.50,高于相应癌旁组织的1.02±0.23(P<0.05)。胃癌组织SphK1蛋白的高表达率为71.0%(22/31),高于相应癌旁组织的38.7%(12/31),差异有统计学意义(P<0.05)。SphK1蛋白与mRNA的表达分别与浸润深度、TNM分期、淋巴结转移及血管侵犯相关,而与年龄、性别及分化程度无关。胃癌组织VEGF蛋白的高表达率为64.5%(20/31),与SphK1蛋白表达呈正相关(r=0.565,P<0.05)。结论 SphK1在胃癌组织中高表达,并可能与VEGF共同促进胃癌的发生和发展。 Objective To investigate the role of Sphingosine kinase-1 ( SphK1 ) in the occurrence and progression of gastric cancer, and its correlation with vascular endothelial growth factor(VEGF). Methods Quantitative real-time reverse transcription-PCR (qRT-PCR) assay was used to determine the expression of SphKl mRNA in 31 cases human gastric cancer tissues and paracarcinoma tissues. Immunohistochemical method(SP) was used to detect the expression of SphK1 and VEGF protein. Results The expression of SphK1 mRNA in gastric cancer and corresponding paracarcinoma tissues was 2. 77 -+ O. 50 and 1.02 +-0. 23 (P 〈 0. 05 ). The high ex- pression rate of SphK1 protein in the gastric cancer tissues was 71.0% (22/31) , higher than 38.7% ( 12/31 ) in the corresponding pa- racarcinoma tissues(P 〈 O. 05). The expression of SphK1 in gastric cancer tissues was correlated with the depth of infiltration, TNM clinical stage, lymph node metastasis and vessel invasion, but not with age, gender and differentiation. The high expression rate of ~EGF protein in the gastric cancer tissues was 64. 5% (20/31). The expression of SphK1 protein were positively related with VEGF protein in gastric cancer(r =0. 565, P 〈 0. 05). Conclusion SphKI highly expresses in gastric cancer, and promote the oecurrenee and progression of gastric cancer in correlation with VEGF.
出处 《临床肿瘤学杂志》 CAS 2012年第12期1076-1080,共5页 Chinese Clinical Oncology
关键词 胃癌 鞘氨醇激酶-1 血管内皮生长因子 Gastric cancer Sphingosine kinase-1 Vascular endothelial growth factor
  • 相关文献

参考文献12

  • 1Saddoughi SA, Song P, Ogremen B. Roles of bioactive sphingo-lipids in cancer biology and therapeutics [ J ]. Subcell Biochem,2008,49: 413 -440.
  • 2Shida D, Takabe K, Kapitonov D, et al. Targeting SphKl as anew strategy against cancer[ J]. Curr Drug Targets,2008 ,9(8):662 -673.
  • 3Li W, Yu CP, Xia JT, et al. Sphingosine kinase 1 is associatedwith gastric cancer progression and poor survival of patients[ J].Clin Cancer Res, 2009,15(4) : 1393 -1399.
  • 4An GY,Baik YH,Choi MG’et al. The prognosis of gastric cardiacancer after R0 resection [ J]. Am J Surg, 2010,199 ( 6 ) : 725-729.
  • 5苏颖洁,黄杰安,刘诗权,黄娟秀,钟月圆,唐国都,姜海行.鞘氨醇激酶1和核因子κB p65在结肠癌中的表达及其临床意义[J].中华内科杂志,2012,51(3):220-224. 被引量:8
  • 6Bayerl MG, Bruqqeman RD, Conroy EJ,et al. Sphingosine ki-nase 1 protein and mRNA are overexpressed in non-Hodgkin lym-phomas and are attractive targets for novel pharmacological inter-ventions[ J]. Leuk Lymphoma, 2008 ,49(5) : 948 -954.
  • 7Facchinetti MM, Gandini NA, Femento ME, et al. The expres-sion of sphingosinnkinase-1 in head and neck carcinoma [ J ].Cells Tissues Organs, 2010,192(5) ; 314 -324.
  • 8Song L,Xiong H, Li J, et al. Sphingosine kinase-1 enhance re-sistance to apoptpsis through activation of PI3 K/Akt/NF-kBpathway in human non-smail cell lung cancer [ J ]. Clin CancerRes, 2011,17(7) : 1839 -1849.
  • 9Sun HY, Wei SP,Xu RC, et al. Sphingosine-1 -phosphate in-duces human endothelial VEGF and MMP-2 priductiong via tran-scription factor ZNF580: Novel insight into an angiogenesis [ J ].Biochem Biophys Res Commun,2010,395(3) : 361 -366.
  • 10Heo K, Park KA, Kim YH, et al. Sphingosine-1 -phosphate in-duces vesicular endothelial growth [ J ]. BMB,2009 ,42 ( 10 ):685 -690.

二级参考文献16

  • 1姜大磊,高艳景,付金栋,宋健华,许建民.SPK/S1P信号途径对人肝癌细胞VEGF表达的作用[J].山东大学学报(医学版),2007,45(3):250-252. 被引量:2
  • 2Bergelin N,Blom T,Heikkila J,et al.Sphingosine kinase as an oncogene:autocrine sphingosine 1-phosphate modulates ML-1thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2.Endocrinology,2009,150:2055-2063.
  • 3Li W,Yu CP,Xia JT,et al.Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients.Clin Cancer Res,2009,15:1393-1399.
  • 4Puvvada SD,Funkhouser WK,Greene K,et al.NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.Oncology,2010,78:181-188.
  • 5Alemany R,Perona JS,Sánchez-Dominguez JM,et al.G proteincoupled receptor systems and their lipid environment in health disorders during aging.Biochim Biophys Acta,2007,1768:964-975.
  • 6Hait NC,Oskeritzian CA,Paugh SW,et al.Sphingosine kinases,sphingosine 1-phosphate,apoptosis and diseases.Biochim Biophys Acta,2006,1758:2016-2026.
  • 7Taha TA,Mullen TD,Obeid LM.A house divided:ceramide,sphingosine,and sphingosine-l-phosphate in programmed cell death.Biochim Biophys Acta,2006,1758:2027-2036.
  • 8Kawamori T,Osta W,Johnson KR,et al.Sphingosine kinase 1 is up-regulated in colon carcinogenesis.FASEB J,2006,20:386-388.
  • 9Xia P,Gamble JR,Wang L,et al.An oncogenic role of sphingosine kinase.Curr Biol,2000,10:1527-1530.
  • 10Staudt LM.Oncogenic activation of NF-kappaB.Cold Spring Harb Perspect Biol,2010,2:a000109.

共引文献13

同被引文献24

  • 1王文勇,唐红卫,张志培,韩彬,高艳红,马福成,闫庆国,赵一岭.胃癌组织中Bag-1和Bcl-2的表达及意义[J].世界华人消化杂志,2005,13(10):1186-1189. 被引量:5
  • 2Li J, Guan HY, Gong LY, et al. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival[J]. Clini Cancer Res, 2008, 14(21): 6996-7003.doi: 10.1158/1078-0432.CCR-08-0754.
  • 3Cuvillier O, Pirianov G, Kleuser B, et al. Suppression of ceramide- mediated programmed cell death by sphingosine-1-phosphate[J]. Nature, 1996, 381(6585):800-803. doi:10.1038/381800a0.
  • 4Shida D, Takabe K, Kapitonov D, et al. Targeting SphK1 as a new strategy against cancer[J]. Current drug targets, 2008, 9(8): 662. doi: 10.2174/138945008785132402.
  • 5Takabe K, Kim RH, Allegood JC, et al. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2[J]. J Biol Chem, 2010, 285(14): 10477-10486.doi:10.1074/ jbc.M109.064162.
  • 6Mutoh T, Rivera R, Chun J. Insights into the pharmacological rele- vance of lysophospholipid receptors[J]. Br J Pharmacol, 2012, 165 (4): 829-844.doi: 10.1111/j. 1476-5381.2011.01622.x.
  • 7Lee H, Deng J, Kujawski M, et al. STAT3-induced S1PR1 expres- sion is crucial for persistent STAT3 activation in tumors[J]. Nat Med, 2010, 16(12): 1421-1428.doi:10.1038/nm.2250.
  • 8Li QF, Wu CT, Guo Q, et al. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis[J]. Biochemi Biophy Res Commun, 2008, 371(1): 159- 162.doi: 10.1016/j.bbrc.2008.04.037.
  • 9Pan J, Tao Y F, Zhou Z, et al. An novel role of sphingosine kinase- 1 (SPHK1) in the invasion and metastasis of esophageal carcinoma [J]. J Transl Med, 2011, 9: 157.doi: 10.1186/1479-5876-9-157.
  • 10Rothwarf D M, Karin M. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus[J]. Sci STKE, 1999, 1999(5): RE1. doi: 10.1126/stke.1999.5.re1.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部